Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo.
Blood. 1997 Dec 15;90(12):4687-98.
Blood. 1997.
PMID: 9389683
Free article.